Noam Solomon (L) and Luis Voloch, Immunai co-founders

Koch leads mam­moth $215M in­fu­sion in­to AI start­up boast­ing 'largest data­base' of im­mune cells

In the three years since Noam Solomon and Luis Voloch start­ed Im­mu­nai, the com­pa­ny has quick­ly out­grown its digs.

Im­mu­nai’s team went from 30 staffers in May 2020 to 120, rep­re­sent­ing 16 na­tion­al­i­ties and spread across five cities — Tel Aviv, New York, San Fran­cis­co, Zurich and Prague — af­ter re­cent­ly ac­quir­ing two com­pa­nies to beef up their data­base and an­a­lyt­ic ca­pa­bil­i­ties. More than 30 groups in bio­phar­ma and acad­e­mia have signed up to use their tech­nolo­gies.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters